Everyone's panicking about (https://www.marketwatch.com/story/this-disease-is-more-expensive-than-cancer-and-heart-disease-combined-and-its-only-going-to-get-worse-797b72d9?mod=mw_rss_topstories) hitting crisis levels. But here's what the crowd's missing: the volume is concentrated in a handful of names, and the ones NOT selling are speaking louder than the ones dumping. UTHR's CFO James Edgemond just sold $2.1B in stock on June 22 — brutal signal.

Research these companies